Political Principles

Social Acceptance of Technologies and Products

The welfare of societies is closely linked to the ability to develop and use new technologies. Bayer trusts in scientific research to determine the risks and benefits of technologies and products. It is in Bayer’s interest to provide safe solutions to today’s and tomorrow’s problems.

Claire Pons de VincentZoom image
Bayer makes a sustainable contribution to overcoming global challenges with its innovative technologies and new research approaches. Laboratory technician Claire Pons de Vincent and her colleagues at Bayer’s wheat research center in Milly-la-Forét, for example, are analyzing more effective breeding methods for the cereal.

Investments in technologies and production facilities span decades, though, and cost millions if not billions. Stable frameworks which make it possible to plan on such timescales are therefore essential to Bayer. This requires a broad and general acceptance of safe new technologies within societies.

While very few people object to medicine created by biotechnology, the benefits of green biotechnology in plants have yet to be accepted by European societies. Since 1996, over 2 billion hectares of Genetically Modified (GM) crops have been cultivated in up to 28 countries.

In 2015, farmers in Africa, Asia and Latin America grew 54 percent of the 180 million hectares of GM crops planted globally.
In Europe, GM plants are approved for import for use in food and animal feed. The cultivation of certain GM plants is allowed in some European countries, for example Spain, Portugal, Czech republic, Slovakia and Romania grew GM maize in 2015.

In food production, crop protection makes an important contribution to reducing hunger in the world and improving the quality of food.

Last updated: October 6, 2016 Copyright © Bayer AG